OI Ljubljana

iPAAC- innovative partnership for action against cancer

Principal investigator at the Institute of Oncology Ljubljana: Urška Ivanuš PhD

The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The development of innovative approaches to cancer control will be supplemented by a Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support Member States in implementation of iPAAC and CANCON recommendations.



© 2019 - Institute of Oncology Ljubljana
color contrast
text size
highlighting content
zoom in